PGx and Biomarker Research Will Feature in Expanded J&J Facility in Pa.

Apr 20, 2007

NEW YORK (GenomeWeb News) — Johnson & Johnson Pharmaceutical Research and Development is expanding its facilities in Spring House, Pa., that will house drug-development research into biomarkers, structural biology, and pharmacogenomics, the company said yesterday.

The new facility, expected to be completed in 2009, will add around 150,000 square feet to the Spring House complex. The company said it plans to keep the 680 employees on the campus, and said it expects to hire 120 more.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Shaken Identity

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Free-Ish

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

This Week in PLOS

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

Isolation Worries

An opinion piece at Bloomberg discusses China's stance on genomic research.

Main menu